MIGUEL
QUIJADA ÁLAMO
Investigador en el periodo 2017-2023
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (2)
2020
-
Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. 548-555.e4
2017
-
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265